In Planet Sex, Cara Delevingne goes on a journey to discover what is known as “lack of orgasm” by being the “guinea pig” of some unorthodox experiments. So much so that she can be seen walking into a university hospital in Berlin and telling the camera that she is about to donate an orgasm to science. The purpose is to show the chemical changes that occur in our bodies when we have an orgasm.
British model and actress Cara Delevingne explores “gender, sexuality and our deepest desires,” in Planet Sex, a new documentary series airing on Britain’s BBC Three.
In Planet Sex, a six-part series starring Cara Delevingne, the model goes on a journey to discover what is known as “lack of orgasm” by being the “guinea pig” of some unorthodox experiments. So much so that she can be seen walking into a university hospital in Berlin, Germany, telling the camera that she is about to donate an orgasm to science.
The purpose of this study is to show the public, through this documentary, the chemical changes that occur in our bodies when we have an orgasm.
Before the experiment began, a blood sample was taken from Cara’s arm, which was then compared to a second sample taken after the orgasm to find out the neurological and biological effects of her orgasm.
According to researchers Johannes Fuss and Sarah Biedermann, Cara’s second blood sample contained endocannabinoids. Endocannabinoids are molecules the body naturally produces that share their effects with phytocannabinoids, the molecules found in cannabis.
“Endocannabinoids are powerful chemicals. They are important for reducing anxiety, increasing euphoria, and having pleasurable sex. So endocannabinoids are sort of your body’s version of cannabis,” says Dr. Fuss.
According to the research, during sex, endocannabinoids increase by up to 44 percent and peak during orgasm.
We’ve looked at the relationship between sex and cannabis before, revealing some surprising connections. So far, it’s been established that our endocannabinoid system can be activated in a number of ways, from exposure to external products, such as cannabis, to sexual stimulation – as Fuss and Bidermann’s work in this area has demonstrated. But this is not the only experiment these researchers have conducted to assess the link between endocannabinoids and sex.
A 2017 study co-authored by Fuss and Biedermann recognized for the first time the association between sex and orgasm and an increase in endocannabinoids, specifically 2-AG.
“The endocannabinoid 2-AG is involved in the human sexual response cycle, and we hypothesized that 2-AG release plays a role in the rewarding consequences of sexual arousal and orgasm,” the researchers concluded.
Another study published in 2019 found that participants who used cannabis were more likely to report increased sexual desire, more satisfying orgasms, and reduced pain than women who did not use cannabis.
While further research is certainly needed to fully understand the role of cannabinoids (both endo and phyto) in sexual pleasure, the current evidence suggests that cannabis and sex can often be a perfect match.
—
(Featured image by Dainis Graveris via Pexels)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The DEA has postponed a key hearing on the reclassification of cannabis. The hearing was…
A new California Department of Public Health report has come out with recommendations for THC…
Ontario is investing $31 million over the next three years to enhance efforts against illegal…
Frankfurt and Hanover are launching five-year pilot projects for legal, regulated cannabis sales to adults,…
Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending…
This November, five U.S. states will vote on measures related to legalizing recreational or medical…